Joshua M. Gulley

Joshua M. Gulley

Auto-generated profile, based on publicly available information

Joshua M. Gulley

Department of Psychology, University of Illinois at Urbana-Champaign, USA; Neuroscience Program, University of Illinois at Urbana-Champaign, USA; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2017 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DWDeena M. Walker
Deena M. Walker
MBMargaret R. Bell
Margaret R. Bell
CFCecilia Flores
Cecilia Flores
JGJoshua M. Gulley
Joshua M. Gulley
JWJari Willing
Jari Willing
MPMatthew J. Paul
Matthew J. Paul
Adolescence is a time of significant neural and behavioral change with remarkable development in social, emotional, and cognitive skills. It is also a time of increased exploration and risk-taking (e.g., drug use). Many of these changes are thought to be the result of increased reward-value coupled with an underdeveloped inhibitory control, and thus a hypersensitivity to reward. Perturbations during adolescence can alter the developmental trajectory of the brain, resulting in long-term alterations in reward-associated behaviors. This review highlights recent developments in our understanding of how neural circuits, pubertal hormones, and environmental factors contribute to adolescent-typical reward-associated behaviors with a particular focus on sex differences, the medial prefrontal cortex, social reward, social isolation, and drug use. We then introduce a new approach that makes use of natural adaptations of seasonally breeding species to investigate the role of pubertal hormones in adolescent development. This research has only begun to parse out contributions of the many neural, endocrine, and environmental changes to the heightened reward sensitivity and increased vulnerability to mental health disorders that characterize this life stage.

1 February 2016 in Behavioural Brain Research
Verified
Journal Article
Closed access
LHLindsey R. Hammerslag
Lindsey R. Hammerslag
JGJoshua M. Gulley
Joshua M. Gulley

1 October 2003 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JGJoshua M. Gulley
Joshua M. Gulley
NZNancy R. Zahniser
Nancy R. Zahniser

10 June 2013 in Developmental Psychobiology
Verified
Journal Article
Closed access
PDF file
LHLindsey R. Hammerslag
Lindsey R. Hammerslag
JGJoshua M. Gulley
Joshua M. Gulley

17 September 2007 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
DHDarien A. Hall
Darien A. Hall
JSJessica J. Stanis
Jessica J. Stanis
HAHector Marquez Avila
Hector Marquez Avila
JGJoshua M. Gulley
Joshua M. Gulley

2 October 2002 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
JGJoshua M. Gulley
Joshua M. Gulley
SDSuzanne Doolen
Suzanne Doolen
NZNancy R. Zahniser
Nancy R. Zahniser
In heterologous expression systems, dopamine transporter (DAT) cell‐surface localization is reduced after relatively prolonged exposure to d‐amphetamine (AMPH) or dopamine (DA), suggesting a role for substrate‐mediated regulation of transporter function. Here, we investigated whether brief, repeated periods of substrate exposure modulated transporter function, first, in an in vitro model system and, second, in intact rat brain. In human DAT‐expressing Xenopus laevis oocytes, repeated exposure to low micromolar concentrations of DA, AMPH or tyramine markedly reduced transport‐mediated currents. This functional down‐regulation was attenuated by inclusion of a protein kinase C (PKC) inhibitor and probably reflects DAT redistribution, as cell‐surface [3H]WIN 35 428 binding was significantly lower following DA exposure. High‐speed chronoamperometry was used to measure clearance of exogenously applied DA in dorsal striatum (STR) and nucleus accumbens (NAc) of anesthetized rats. In STR, frequent (every 2 min) applications of DA altered DA clearance parameters in a manner consistent with profound down‐regulation of DAT function. Similar changes were not observed in NAc or after repeated vehicle (ascorbic acid) application. Together, our results suggest that brief, repeated periods of substrate exposure lead to rapid down‐regulation of DAT activity and that this type of regulation can occur in vivo in STR, but not NAc.